Spitting into the wind – Allergan sues the FDA about freedom of speech (esp. off-label discussions). This particular legal discussion needs to happen, actually – but it takes a brass pair to be the one filing the suit!
Genentech’s Lucentis: effective in a week in study – The optical drug Lucentis proved effective in two late-stage studies in improving the vision of patients with retinal vein occlusion as early as the seventh day of treatment, Genentech said on Sunday…more
Compliance Training. The Impactiviti Partner Network has great providers to help you with this need – for sales reps or corporate employees; on-line or traditional. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
A doctor’s office you may just want to skip!
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Connect with Steve Woodruff